Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 2
1949 3
1960 1
1962 2
1965 3
1966 3
1967 4
1968 5
1969 1
1970 5
1971 7
1972 3
1973 3
1974 1
1975 2
1976 4
1977 1
1978 2
1979 6
1981 1
1982 2
1983 2
1985 2
1986 8
1987 2
1988 5
1989 8
1990 2
1991 2
1992 4
1993 3
1994 9
1995 6
1996 6
1997 5
1998 5
1999 8
2000 7
2001 4
2002 8
2003 7
2004 7
2005 10
2006 9
2007 20
2008 17
2009 16
2010 16
2011 19
2012 13
2013 22
2014 29
2015 35
2016 39
2017 54
2018 56
2019 66
2020 57
2021 75
2022 93
2023 89
2024 158
2025 168
2026 140

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,226 results

Results by year

Filters applied: . Clear all
Page 1
Transplantation of encapsulated mitochondria alleviates dysfunction in mitochondrial and Parkinson's disease models.
Du S, Long Q, Zhou Y, Fu J, Wu H, Yang L, Xie Y, Ding Y, Zhang M, Guo J, Wang M, Lin J, Hu M, Zhang J, Yao D, Li W, Bao F, Xiang G, Wu Y, Huang Y, Liang H, Wang R, Li H, Chen B, Li C, Wang J, Zhang J, Qin D, Sun J, Zhu Y, Sun F, Wang W, Lu G, Chan WY, Zhao H, Liu C, Liu X. Du S, et al. Cell. 2026 May 14;189(10):2821-2833.e23. doi: 10.1016/j.cell.2026.02.023. Epub 2026 Mar 18. Cell. 2026. PMID: 41856111
Mitochondrial transplantation holds significant potential for the treatment of mitochondrial diseases. However, how to efficiently deliver exogenous mitochondria to somatic cells or tissues remains unresolved. ...Furthermore, mitochondrial capsules rescued the mitochondria …
Mitochondrial transplantation holds significant potential for the treatment of mitochondrial diseases. However, how to efficiently de …
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease.
Pagano G, Taylor KI, Anzures Cabrera J, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Brockmann K, Svoboda H, Trundell D, Monnet A, Doody R, Fontoura P, Kerchner GA, Brundin P, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Nat Med. 2024 Apr;30(4):1096-1103. doi: 10.1038/s41591-024-02886-y. Epub 2024 Apr 15. Nat Med. 2024. PMID: 38622249 Free PMC article.
Prasinezumab, a monoclonal antibody that binds aggregated alpha-synuclein, is being investigated as a potential disease-modifying therapy in early-stage Parkinson's disease. Although in the PASADENA phase 2 study, the primary endpoint (Movement Disorde …
Prasinezumab, a monoclonal antibody that binds aggregated alpha-synuclein, is being investigated as a potential disease-modifying the …
The mutation spectrum of Parkinson-disease-related genes in early-onset Parkinson's disease in ethnic Chinese.
Chen YP, Yu SH, Zhang GH, Hou YB, Gu XJ, Ou RW, Shen Y, Song W, Chen XP, Zhao B, Cao B, Zhang LY, Sun MM, Liu FF, Wei QQ, Liu KC, Lin JY, Yang TM, Yang J, Wu Y, Jiang Z, Liu J, Cheng YF, Xiao Y, Su WM, Feng F, Cai YY, Li SR, Hu T, Yuan XQ, Zhou QQ, Shao N, Ma S, Shang HF. Chen YP, et al. Eur J Neurol. 2022 Nov;29(11):3218-3228. doi: 10.1111/ene.15509. Epub 2022 Aug 4. Eur J Neurol. 2022. PMID: 35861376
BACKGROUND AND PURPOSE: Recent genetic progress has shown many causative/risk genes linked to Parkinson's disease (PD), mainly in patients of European ancestry. The study aimed to investigate the PD-related genes and determine the mutational spectrum of early …
BACKGROUND AND PURPOSE: Recent genetic progress has shown many causative/risk genes linked to Parkinson's disease (PD), …
Mechanisms of motor symptom improvement by long-term Tai Chi training in Parkinson's disease patients.
Li G, Huang P, Cui SS, Tan YY, He YC, Shen X, Jiang QY, Huang P, He GY, Li BY, Li YX, Xu J, Wang Z, Chen SD. Li G, et al. Transl Neurodegener. 2022 Feb 7;11(1):6. doi: 10.1186/s40035-022-00280-7. Transl Neurodegener. 2022. PMID: 35125106 Free PMC article. Clinical Trial.
BACKGROUND: Tai Chi has been shown to improve motor symptoms in Parkinson's disease (PD), but its long-term effects and the related mechanisms remain to be elucidated. ...
BACKGROUND: Tai Chi has been shown to improve motor symptoms in Parkinson's disease (PD), but its long-term effects and …
Neuroimaging of Parkinson's disease by quantitative susceptibility mapping.
Guan X, Lancione M, Ayton S, Dusek P, Langkammer C, Zhang M. Guan X, et al. Neuroimage. 2024 Apr 1;289:120547. doi: 10.1016/j.neuroimage.2024.120547. Epub 2024 Feb 18. Neuroimage. 2024. PMID: 38373677 Free article. Review.
Parkinson's disease (PD) is a common neurodegenerative disease, and apart from a few rare genetic causes, its pathogenesis remains largely unclear. ...The initiation of multi-site research is warranted for developing robust, interpretable, and disea …
Parkinson's disease (PD) is a common neurodegenerative disease, and apart from a few rare genetic causes, its pa …
TMEM106B deficiency exacerbates alpha-synuclein aggregation in Parkinson's disease.
Meng L, Liu C, Li M, Gong H, Gu X, Zou W, Liu H, Teng H, Xiong J, Zhang Z. Meng L, et al. Brain. 2026 Sep 7;149(9):3150-3165. doi: 10.1093/brain/awag065. Brain. 2026. PMID: 41699905
Parkinson's disease is an age-related neurodegenerative disease that is characterized by the deposition of alpha-synuclein aggregates in the brain. ...TMEM106B is a lysosomal transmembrane protein that has been reported to be associated with brain agei …
Parkinson's disease is an age-related neurodegenerative disease that is characterized by the deposition of alpha …
Microglial CR3 promotes neuron ferroptosis via NOX2-mediated iron deposition in rotenone-induced experimental models of Parkinson's disease.
Wang Q, Liu J, Zhang Y, Li Z, Zhao Z, Jiang W, Zhao J, Hou L, Wang Q. Wang Q, et al. Redox Biol. 2024 Nov;77:103369. doi: 10.1016/j.redox.2024.103369. Epub 2024 Sep 24. Redox Biol. 2024. PMID: 39357423 Free PMC article.
The activation of complement receptor 3 (CR3) in microglia contributes to neurodegeneration in neurological disorders, including Parkinson's disease (PD). However, it remains unclear for mechanistic knowledge on how CR3 mediates neuronal damage. ...
The activation of complement receptor 3 (CR3) in microglia contributes to neurodegeneration in neurological disorders, including Parkinso …
Alzheimer's disease traits in Parkinson's disease without alpha-synuclein seeding.
Fernandes Gomes B, Farris CM, Ma Y, Concha-Marambio L, Nilsson J, Forsberg K, Lebovitz R, Andreasson U, Blennow K, Zetterberg H, Bäckström D. Fernandes Gomes B, et al. Alzheimers Dement. 2025 May;21(5):e70284. doi: 10.1002/alz.70284. Alzheimers Dement. 2025. PMID: 40874677 Free PMC article.
INTRODUCTION: The alpha-synuclein (alphaSyn) seed amplification assay (alphaSyn-SAA) is an accurate tool to detect alphaSyn seeds in patients with Parkinson's disease (PD). However, a minority of clinically diagnosed PD patients are negative for alphaSyn. ... …
INTRODUCTION: The alpha-synuclein (alphaSyn) seed amplification assay (alphaSyn-SAA) is an accurate tool to detect alphaSyn seeds in patient …
Cerebellar transcranial magnetic stimulation improves motor function in Parkinson's disease.
Grobe-Einsler M, Baljasnikowa V, Faikus A, Schaprian T, Kaut O. Grobe-Einsler M, et al. Ann Clin Transl Neurol. 2024 Oct;11(10):2673-2684. doi: 10.1002/acn3.52183. Epub 2024 Sep 5. Ann Clin Transl Neurol. 2024. PMID: 39238196 Free PMC article. Clinical Trial.
OBJECTIVE: To determine whether an accelerated protocol of 48 Hz cerebellar repetitive transcranial magnetic stimulation results in improved motor function in individuals with Parkinson's disease. METHODS: In this double-blind randomized sham-controlled study …
OBJECTIVE: To determine whether an accelerated protocol of 48 Hz cerebellar repetitive transcranial magnetic stimulation results in improved …
Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson's disease: guideline "Parkinson's disease" of the German Society of Neurology.
Fanciulli A, Sixel-Döring F, Buhmann C, Krismer F, Hermann W, Winkler C, Woitalla D, Jost WH; German Parkinson’s Guideline Group; Trenkwalder C, Höglinger G. Fanciulli A, et al. J Neurol. 2025 Jan 3;272(1):90. doi: 10.1007/s00415-024-12730-5. J Neurol. 2025. PMID: 39751950 Free PMC article. Review.
BACKGROUND AND OBJECTIVE: Non-motor symptoms frequently develop throughout the disease course of Parkinson's disease (PD), and pose affected individuals at risk of complications, more rapid disease progression and poorer quality of life. Address …
BACKGROUND AND OBJECTIVE: Non-motor symptoms frequently develop throughout the disease course of Parkinson's disease …
1,226 results